Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “BOARD OF REGENTS”

2,639 pharma patents match "BOARD OF REGENTS" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,639
Index total 30,257
Page 73 / 110

Quick answer

This filtered view shows 2,639 pharmaceutical patents matching "BOARD OF REGENTS" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,639 results for “BOARD OF REGENTS” · 30,257 patents in full index Clear search

  1. US 8518870

    Compositions and methods for cancer treatment using targeted carbon nanotubes

    The Board of Regents of the University of Oklahoma · Granted Aug 27, 2013 · Expires Aug 22, 2033

    granted

  2. US 8513209

    Micro-RNAS of the MIR-15 family modulate cardiomyocyte survival and cardiac repair

    The Board of Regents of the University of Texas System · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted

  3. US 8507445

    Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer

    The Board of Regents of the University of Texas System · Granted Aug 13, 2013 · Expires Aug 8, 2033

    granted

  4. US 8507437

    Apoptosis-modulating p53 protein therapy for vascular disorders and nanoparticles containing the same

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Aug 13, 2013 · Expires Aug 8, 2033

    granted

  5. US 8501740

    Methods of treatment of opioid tolerance, physical dependence, pain and addiction with inhibitors of certain growth factor receptors

    The Board of Regents of the University of Texas System · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted

  6. US 8501705

    Methods and materials for treating autoimmune and/or complement mediated diseases and conditions

    The Board of Regents of the University of Texas System · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted

  7. US 8501423

    Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays

    The Board of Regents of the University of Texas System · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted

  8. US 8491890

    Methods and compositions for inhibiting diseases of the central nervous system

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  9. US 8486410

    RLIP76 liposomes for protection against irradiation

    The Board of Regents of the University of Texas System · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

  10. US 8486391

    Cancer treatment kits using antibodies to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

  11. US 8486909

    Compositions and methods for the diagnosis and treatment of inflammatory disorders and fibrotic disease

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

  12. US 8486428

    Compositions and methods for making and using acyclic N-halamine-based biocidal polymeric materials and articles

    The Board of Regents of the University of Texas System · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

  13. US 8486423

    Thermo-kinetic mixing for pharmaceutical applications

    The Board of Regents of the University of Texas System · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

  14. US 8480637

    Nanochanneled device and related methods

    The Board of Regents of the University of Texas System · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  15. US 8481529

    Combination cancer chemotherapy

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  16. US 8481507

    Micro-RNAs that control myosin expression and myofiber identity

    The Board of Regents of the University of Texas System · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  17. US 8475792

    Molecules with extended half-lives, compositions and uses thereof

    Board of Regents, The Texas University System · Granted Jul 2, 2013 · Expires Jun 27, 2033

    granted

  18. US 8470528

    Methods and compositions related to adenoassociated virus-phage particles

    The Board of Regents of the University of Texas System · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted

  19. US 8470976

    Methods and compositions for targeting macromolecules into the nucleus

    The Board of Regents of the University of Texas System · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted

  20. US 8466154

    Methods and compositions related to wrapping of dehydrons

    The Board of Regents of the University of Texas System · Granted Jun 18, 2013 · Expires Jun 13, 2033

    granted

  21. US 8465755

    Recombinant bacterium capable of eliciting an immune response against enteric pathogens

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jun 18, 2013 · Expires Jun 13, 2033

    granted

  22. US 8455621

    Influenza A virus vaccines and inhibitors

    The Board of Regents of the University of Texas System · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  23. US 8450278

    MUC18 targeting peptides

    The Board of Regents of the University of Texas System · Granted May 28, 2013 · Expires May 23, 2033

    granted

  24. US 8445254

    Regulated expression of antigen and/or regulated attentuation to enhance vaccine immunogenicity and/or safety

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted May 21, 2013 · Expires May 16, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.